Efficacy and safety of long-term entecavir therapy in a European population

Academic Article
Publication Date:
2018
abstract:
Background: Therapy in chronic hepatitis B (chronic hepatitis B) patients aims at improving their survival by preventing disease progression to cirrhosis and its complications. Entecavir (ETV) is currently a first line therapeutic agent recommended for the treatment of CHB. Our aim was to evaluate the long term outcome of a cohort of CHB patients treated with ETV.
Iris type:
01.01 Articolo in rivista
Keywords:
Liver; Hepatitis B; chronic; Entecavir
List of contributors:
Authors of the University:
Handle:
https://iris.cnr.it/handle/20.500.14243/429050
Published in:
MINERVA GASTROENTEROLOGICA
Journal